01463nas a2200505   4500000000100000000000100001008004100002653001100043653001000054653006700064653002300131653002600154653002600180653002900206653002200235653003100257653002000288653001900308653001800327653002300345653002200368653001900390653001400409653002500423653002200448653002500470100001500495700001300510700001300523700001200536700001500548700001600563700001200579700001200591700001500603700001500618700001300633700001300646700001500659245021600674250001500890300001400905490000700919020003100926       2023                            d10aHumans10aAdult10a*Pulmonary Disease, Chronic Obstructive/diagnosis/drug therapy10aTiotropium Bromide10aBronchodilator Agents10aRetrospective Studies10aForced Expiratory Volume10aTreatment Outcome10aAdministration, Inhalation10aBenzyl Alcohols10aChlorobenzenes10aQuinuclidines10aDrug Prescriptions10aDrug Combinations10aCOPD treatment10aLaba/lama10aprimary care setting10arescue medication10atreatment escalation1 aG. Requena1 aA. Czira1 aV. Banks1 aR. Wood1 aT. Tritton1 aC. Castillo1 aJ. Yeap1 aR. Wild1 aC. Compton1 aK. Rothnie1 aF. Herth1 aJ. Quint1 aA. Ismaila00aComparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England  a2023/07/19  a1431-14440 v18  a1176-9106 (Print)1176-9106